Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder
Reason given: Slow enrollment
Key facts
- Where
- Jacksonville, United StatesSee the site
Where in United States
- Mayo Clinic FloridaJacksonville, United StatesNo longer taking part
Trial details
- Who runs it
- Mayo Clinic
- Trial code
- NCT05307770
- Record updated
- 29 May 2024
- Original description
The purpose of this research is to compare the efficacy of immediate versus extended-release melatonin as a supplement affecting the sleep cycle in patients with Parkinson disease and Rapid Eye Movement Sleep Behavior Disorder.Read full original descriptionShow less
Randomized, Double-Blind, Cross-Over Study Comparing the Efficacy of Immediate and Extended-Release Melatonin as a Supplement Affecting the Sleep Cycle in Patients With Parkinson Disease and Rapid Eye Movement Sleep Behavior Disorder
The purpose of this research is to compare the efficacy of immediate versus extended-release melatonin as a supplement affecting the sleep cycle in patients with Parkinson disease and Rapid Eye Movement Sleep Behavior Disorder.
Inclusion: Diagnosed with Parkinson's disease and rapid eye movement sleep behavior disorder; Patient registered to Parkinson's disease database of Mayo Clinic Florida.
Exclusion: Patients who are using other sleep aids or medications (Clonazepam); Patients who are not willing to undertake 1 week of washout period; Patients who do not sign a consent for research.